Upregulation Of Fam46a Conferred Ovarian Cancer To Cddp Resistance In

Upregulation of FAM46A conferred ovarian cancer to CDDP resistance in ...
Upregulation of FAM46A conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Downregulation of FAM46A sensitized ovarian cancer to CDDP treatment in ...
Downregulation of FAM46A sensitized ovarian cancer to CDDP treatment in ...
Downregulation of FAM46A sensitized ovarian cancer to CDDP treatment in ...
Downregulation of FAM46A sensitized ovarian cancer to CDDP treatment in ...
Upregulation of GLT8D2 confers CDDP resistance in ovarian cancer in ...
Upregulation of GLT8D2 confers CDDP resistance in ovarian cancer in ...
Upregulation of RNF149 conferred ESCC to CDDP resistance in vitro. A ...
Upregulation of RNF149 conferred ESCC to CDDP resistance in vitro. A ...
Upregulation of RNF149 conferred ESCC to CDDP resistance in vitro. A ...
Upregulation of RNF149 conferred ESCC to CDDP resistance in vitro. A ...
Redox regulation of the CDDP resistance of ovarian cancer cells is ...
Redox regulation of the CDDP resistance of ovarian cancer cells is ...
Generation of ovarian cancer cells resistant to CDDP and PTX. (A ...
Generation of ovarian cancer cells resistant to CDDP and PTX. (A ...
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted ...
Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted ...
Generation of ovarian cancer cells resistant to CDDP and PTX. (A ...
Generation of ovarian cancer cells resistant to CDDP and PTX. (A ...
Quantification of cDDP antitumor effect in the different ovarian cancer ...
Quantification of cDDP antitumor effect in the different ovarian cancer ...
Upregulation of RNF149 confers CDDP resistance in ESCC in vivo. A GSEA ...
Upregulation of RNF149 confers CDDP resistance in ESCC in vivo. A GSEA ...
Generation of ovarian cancer cells resistant to CDDP and PTX. (A ...
Generation of ovarian cancer cells resistant to CDDP and PTX. (A ...
Overexpression of FAM46A correlates with ovarian cancer progression and ...
Overexpression of FAM46A correlates with ovarian cancer progression and ...
Overexpression of FAM46A correlates with ovarian cancer progression and ...
Overexpression of FAM46A correlates with ovarian cancer progression and ...
FAO upregulation is associated with poor prognosis in ovarian cancer ...
FAO upregulation is associated with poor prognosis in ovarian cancer ...
cDDP and metformin treatment in ovarian cancer PDXs. Antitumor activity ...
cDDP and metformin treatment in ovarian cancer PDXs. Antitumor activity ...
Frontiers | Emerging role of m6A modification in ovarian cancer ...
Frontiers | Emerging role of m6A modification in ovarian cancer ...
Developments in Genetics: Better Management of Ovarian Cancer Patients
Developments in Genetics: Better Management of Ovarian Cancer Patients
Depletion of circ_0026359 decreased CDDP resistance of gastric cancer ...
Depletion of circ_0026359 decreased CDDP resistance of gastric cancer ...
Depletion of circ_0026359 decreased CDDP resistance of gastric cancer ...
Depletion of circ_0026359 decreased CDDP resistance of gastric cancer ...
Upregulation of TRIM31 conferred gemcitabine resistance on pancreatic ...
Upregulation of TRIM31 conferred gemcitabine resistance on pancreatic ...
Clinical relevance of FAM46A-induced TGF-β activation in human ovarian ...
Clinical relevance of FAM46A-induced TGF-β activation in human ovarian ...
FAM46A up-regulation activates the TGF-β signaling pathway in ovarian ...
FAM46A up-regulation activates the TGF-β signaling pathway in ovarian ...
Frontiers | Regulation of ovarian cancer by protein post-translational ...
Frontiers | Regulation of ovarian cancer by protein post-translational ...
Suppression of Ovarian Cancer Cell Proliferation Is Associated with ...
Suppression of Ovarian Cancer Cell Proliferation Is Associated with ...

Loading image details...

Source
Dimensions